Wave Life Sciences CEO Paul Bolno Sells $750,000 in Shares
Truist Financial Maintains Wave Life Sciences(WVE.US) With Buy Rating
Wave Life Sciences to Present at Upcoming Investor Conferences
In 2025, US Biotech stocks are expected to rise significantly. jpmorgan's top pick is vertex pharmaceuticals (VRTX.US).
Vertex pharmaceuticals (Vertex) ranked first on the list of US biotechnology stock selections for 2025 released by jpmorgan.
Vertex Leads J.P. Morgan's Top Biotech Picks List for 2025
Wave Life Sciences Is Maintained at Outperform by Mizuho